FDA accelerated approval makes sevabertinib available for previously treated advanced nonsquamous NSCLC with qualifying HER2 mutations, emphasizing precise molecular testing and avoiding broad HER2…
FDA approved lirafugratinib for previously treated advanced FGFR2-rearranged cholangiocarcinoma, making validated molecular testing essential for identifying eligible patients and guiding targeted…
American Regent recalled a papaverine injection lot after particulate matter findings, prompting quarantine, inventory tracing, exposure assessment, symptom monitoring, and urgent evaluation for…
FDA granted accelerated approval to sevabertinib for select HER2-mutated non-squamous NSCLC, requiring precise molecular eligibility while confirmatory studies establish clinical benefit.
ASTRUM-006 found serplulimab plus perioperative SOX improved event-free survival in PD-L1-selected resectable gastric or gastroesophageal junction cancer, supporting biomarker-guided investigation.
Randomized evidence found fecal microbiota transplantation more effective than vancomycin or fidaxomicin for recurrent C. difficile infection, supporting microbiota restoration after repeated…
The 2026 universal heart failure definition standardizes diagnosis and documentation across care settings, potentially affecting referrals, coding, research criteria, and local implementation…
ITACS evaluates preoperative intravenous iron for anemia before cardiac surgery, but its supplied citation lacks results needed to determine effects on transfusion, recovery, or safety.
Endocrine Society guidance discourages routine brain MRI for selected children with central precocious puberty, emphasizing neurologic assessment and individualized imaging when concerning findings…
